NDC 0781-2321 – Aprepitant
Aprepitant 40 mg/1 · Capsule · Oral
Product NDC0781-2321
Product details
- Brand name
- Aprepitant
- Generic name
- Aprepitant
- Labeler
- Sandoz Inc
- Dosage form
- Capsule
- Route
- Oral
- Marketing category
- ANDA · ANDA090999
- Marketed since
- December 27, 2016
- Listing expires
- December 31, 2026
- Pharmacologic class
- Substance P/Neurokinin-1 Receptor Antagonist
Active ingredients
- Aprepitant 40 mg/1
Package NDC codes (2)
| Package NDC | Description | Since |
|---|---|---|
| 0781-2321-06 | 1 BLISTER PACK in 1 CARTON (0781-2321-06) / 1 CAPSULE in 1 BLISTER PACK | Dec 27, 2016 |
| 0781-2321-51 | 5 BLISTER PACK in 1 CARTON (0781-2321-51) / 1 CAPSULE in 1 BLISTER PACK | Dec 27, 2016 |
Recalls mentioning this NDC
- D-1027-2022 Jun 15, 2022 · Class II
cGMP deviations: Temperature abuse
Other Aprepitant products
- 68001-668 Aprepitant 125 mg/1 · Capsule · BluePoint Laboratories
- 68001-667 Aprepitant 80 mg/1 · Capsule · BluePoint Laboratories
- 68001-666 Aprepitant 40 mg/1 · Capsule · BluePoint Laboratories
- 68462-585 Aprepitant 125 mg/1 · Capsule · Glenmark Pharmaceuticals Inc., USA
- 68462-584 Aprepitant 80 mg/1 · Capsule · Glenmark Pharmaceuticals Inc., USA
- 68462-583 Aprepitant 40 mg/1 · Capsule · Glenmark Pharmaceuticals Inc., USA
- 51407-703 Aprepitant 125 mg/1 · Capsule · Golden State Medical Supply, Inc.
- 51407-702 Aprepitant 80 mg/1 · Capsule · Golden State Medical Supply, Inc.
- 51407-701 Aprepitant 40 mg/1 · Capsule · Golden State Medical Supply, Inc.
- 0781-2322 Aprepitant 80 mg/1 · Capsule · Sandoz Inc
- 0781-2323 Aprepitant 125 mg/1 · Capsule · Sandoz Inc
- 13668-593 Aprepitant 125 mg/1 · Capsule · Torrent Pharmaceuticals Limited